ENDRA Life Sciences Inc. (NDRA) stock
NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)
Close on Nov 18, 2026Market cap $6.05MP/E –Yield –
ENDRA Life Sciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ENDRA Life Sciences's enterprise value was $5.41M on Nov 11, 2026, against $3.86M a year earlier. Over the last 5 years it ranged from -$2.17M to $2.53T, with a median of $963.94M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.41M | +95.4% |
| 2025 | Dec 31, 2025 | $2.77M | – |
| 2024 | Dec 31, 2024 | -$1.40M | -100.0% |
| 2023 | Dec 29, 2023 | $31.21B | -93.1% |
| 2022 | Dec 30, 2022 | $449.97B | -55.9% |
| 2021 | Dec 31, 2021 | $1.02T | +55.5% |
| 2020 | Dec 31, 2020 | $656.69B | +48.6% |
| 2019 | Dec 31, 2019 | $442.01B | +113.3% |
| 2018 | Dec 31, 2018 | $207.27B | -68.8% |
| 2017 | Dec 29, 2017 | $664.65B | – |
See a number that looks wrong?